EP1311276A4 - Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes - Google Patents

Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes

Info

Publication number
EP1311276A4
EP1311276A4 EP01959852A EP01959852A EP1311276A4 EP 1311276 A4 EP1311276 A4 EP 1311276A4 EP 01959852 A EP01959852 A EP 01959852A EP 01959852 A EP01959852 A EP 01959852A EP 1311276 A4 EP1311276 A4 EP 1311276A4
Authority
EP
European Patent Office
Prior art keywords
preventing
conditions
methods
treating diseases
complex carbohydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01959852A
Other languages
German (de)
English (en)
Other versions
EP1311276A1 (fr
Inventor
Harold G Brown
Karen K Brown
Carol A Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermal Research Laboratories Inc
Original Assignee
Dermal Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermal Research Laboratories Inc filed Critical Dermal Research Laboratories Inc
Publication of EP1311276A1 publication Critical patent/EP1311276A1/fr
Publication of EP1311276A4 publication Critical patent/EP1311276A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01959852A 2000-07-31 2001-07-31 Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes Withdrawn EP1311276A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22204600P 2000-07-31 2000-07-31
US222046P 2000-07-31
PCT/US2001/041473 WO2002009728A1 (fr) 2000-07-31 2001-07-31 Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes

Publications (2)

Publication Number Publication Date
EP1311276A1 EP1311276A1 (fr) 2003-05-21
EP1311276A4 true EP1311276A4 (fr) 2007-09-12

Family

ID=22830558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01959852A Withdrawn EP1311276A4 (fr) 2000-07-31 2001-07-31 Procedes servant a prevenir ou a traiter des maladies et des etats au moyen de glucides complexes

Country Status (5)

Country Link
EP (1) EP1311276A4 (fr)
AU (2) AU2001281368B2 (fr)
CA (1) CA2417867C (fr)
NZ (2) NZ533078A (fr)
WO (1) WO2002009728A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
WO2002060471A2 (fr) * 2001-01-30 2002-08-08 Ich Productions Limited Ligands des proteines tyrosine phosphatases de type recepteur
ITMI20021866A1 (it) * 2002-08-30 2004-02-29 Luigi Allegra Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US20070225484A1 (en) * 2006-03-25 2007-09-27 Framroze Bomi P Process for the Isolation and Stabilization of Low-Molecular Weight Aminoglycans from Waste Egg Shells
CN101437527A (zh) * 2006-05-11 2009-05-20 桑德拉·戈博 透明质酸二元混合物及其治疗用途
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
EA018333B1 (ru) * 2008-05-13 2013-07-30 Афарм С.Р.Л. Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
US9241953B2 (en) 2008-05-13 2016-01-26 Apharm S.R.L. Glycosaminoglycan oral use and compositions
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
FR2959415B1 (fr) * 2010-04-30 2012-07-13 Ayawane Composition dermatologique a base d'huile d'argan et d'acide hyaluronique.
FI20115631A0 (fi) 2011-06-21 2011-06-21 Turun Yliopisto Immunostimulatoriset yhdisteet ja niiden käyttö
ITMI20130117A1 (it) * 2013-01-25 2014-07-26 Gnosis Spa Composizioni comprendenti condroitin solfato, enzimi proteolitici e composti sulfidrilati capaci di migliorare la biodisponibilita' del condroitin solfato
CN118902992A (zh) * 2016-04-25 2024-11-08 惠觅宙 一种含有小分子透明质酸的注射液的用途
CN108721320A (zh) * 2017-04-24 2018-11-02 惠觅宙 小分子透明质酸片段的应用
US11576925B2 (en) * 2016-04-25 2023-02-14 Mizhou Hui Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
EP4072590A4 (fr) * 2019-12-13 2024-01-03 Folium Labs Inc. Complexes comprenant un polymère de glucide et un principe actif et leurs procédés de préparation
CN117679520A (zh) * 2022-09-09 2024-03-12 北京达尔文细胞生物科技有限公司 用于防治后遗症期面神经麻痹的药物组合物及其应用

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005517A1 (fr) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Sels de metaux lourds de l'acide hyaluronique utiles en tant qu'agents antimicrobiens
EP0254845A2 (fr) * 1986-06-10 1988-02-03 Lescarden Inc. Stimulation d'immunité avec le chondroitine sulfate
WO1988001280A1 (fr) * 1986-08-21 1988-02-25 Board Of Regents, The University Of Texas System Derives de glycosaminoglycane et leur utilisation comme inhibiteurs de l'invasion tumorale ou proliferation metastatique
WO1991013624A1 (fr) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Glycosaminoglycans sulfates endogenes induits par suramine, utilises comme agents anti-cancereux chez l'homme
EP0509120A1 (fr) * 1991-04-18 1992-10-21 LABORATORI BALDACCI Spa Utilisation topique de glycosaminoglycanes pour la prévention et le traitement des maladies du tractus cervicovaginal
WO1996006622A1 (fr) * 1991-07-03 1996-03-07 Hyal Pharmaceutical Corporation Acide hyaluronique et derives destines a la modulation de l'activite cellulaire
WO1997040841A1 (fr) * 1996-04-29 1997-11-06 Hyal Pharmaceutical Corporation Emploi de formes d'acide hyaluronique (ha) pour therapie anticancereuse
US5929050A (en) * 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
WO2000008061A1 (fr) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Produits de reaction d'acide hyaluronique et d'acides amines naturels et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005517A1 (fr) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Sels de metaux lourds de l'acide hyaluronique utiles en tant qu'agents antimicrobiens
EP0254845A2 (fr) * 1986-06-10 1988-02-03 Lescarden Inc. Stimulation d'immunité avec le chondroitine sulfate
WO1988001280A1 (fr) * 1986-08-21 1988-02-25 Board Of Regents, The University Of Texas System Derives de glycosaminoglycane et leur utilisation comme inhibiteurs de l'invasion tumorale ou proliferation metastatique
WO1991013624A1 (fr) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Glycosaminoglycans sulfates endogenes induits par suramine, utilises comme agents anti-cancereux chez l'homme
EP0509120A1 (fr) * 1991-04-18 1992-10-21 LABORATORI BALDACCI Spa Utilisation topique de glycosaminoglycanes pour la prévention et le traitement des maladies du tractus cervicovaginal
WO1996006622A1 (fr) * 1991-07-03 1996-03-07 Hyal Pharmaceutical Corporation Acide hyaluronique et derives destines a la modulation de l'activite cellulaire
WO1997040841A1 (fr) * 1996-04-29 1997-11-06 Hyal Pharmaceutical Corporation Emploi de formes d'acide hyaluronique (ha) pour therapie anticancereuse
US5929050A (en) * 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
WO2000008061A1 (fr) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Produits de reaction d'acide hyaluronique et d'acides amines naturels et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199341, Derwent World Patents Index; AN 1993-325668, XP002445595 *
See also references of WO0209728A1 *

Also Published As

Publication number Publication date
CA2417867A1 (fr) 2002-02-27
CA2417867C (fr) 2012-09-11
WO2002009728A1 (fr) 2002-02-07
AU2001281368B2 (en) 2005-07-28
NZ533078A (en) 2006-11-30
NZ524076A (en) 2004-07-30
AU8136801A (en) 2002-02-13
EP1311276A1 (fr) 2003-05-21

Similar Documents

Publication Publication Date Title
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
EP1200086A4 (fr) Procedes therapeutiques ou prophylactiques de la douleur et de l'anxiete
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
EP1217963A4 (fr) Dispositifs et procedes de traitement de tissu
EP1283702A4 (fr) Ensemble de pansements medicaux et leur procede d'utilisation
AU1166502A (en) Human ect2 and methods of use
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
IL160835A0 (en) Catheter and method of using same
EP1463495A4 (fr) Agents et procedes de traitement du cancer
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
EP1265583A4 (fr) Procede permettant de traiter un etat de la peau
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
IL138692A0 (en) Treatment and prevention of vascular disease
IL148202A0 (en) Copolymers and methods of treating prion-related diseases
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
GB2360453B (en) Treatment of skin conditions
EP1190089A4 (fr) Methode de traitement utilisant lig 72a et des variants de ce ligand
AU6970101A (en) Method for treatment and prevention of mastitis
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
GB0008921D0 (en) Method of treatment
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
EP1303281A4 (fr) Methodes de traitement
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
GB0030866D0 (en) Treatment and prevention of disease
GB0016197D0 (en) Treatment and prevention of disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030211

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20070816

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071115